| Completed | The Effect of Apple Fruit Extract (Malus Sylvestris Mill) as an Antioxidant and Anti-Inflammatory on Allergic NCT07380178 | Universitas Sebelas Maret | N/A |
| Not Yet Recruiting | Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis NCT06577077 | Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
| Withdrawn | Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis NCT02988778 | Eurofarma Laboratorios S.A. | Phase 3 |
| Completed | Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age NCT03286049 | Istituto per la Ricerca e l'Innovazione Biomedica | — |
| Withdrawn | Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis NCT02972866 | Eurofarma Laboratorios S.A. | Phase 3 |
| Unknown | Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis. NCT02653339 | Peking Union Medical College Hospital | N/A |
| Completed | Repeated Dosing Clinical Trial of HL151 NCT02686294 | Hanlim Pharm. Co., Ltd. | Phase 1 |
| Completed | Single Dosing Clinical Trial of HL151 NCT02682745 | Hanlim Pharm. Co., Ltd. | Phase 1 |
| Completed | Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-ass NCT02443805 | Stallergenes Greer | Phase 3 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 NCT02498509 | Chong Kun Dang Pharmaceutical | Phase 3 |
| Completed | Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis NCT02339714 | Zhao Hong | Phase 2 |
| Completed | Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic R NCT01700192 | ALK-Abelló A/S | Phase 3 |
| Completed | Probiotic Administration and Perennial Allergic Rhinitis NCT01779895 | Société des Produits Nestlé (SPN) | N/A |
| Completed | A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Indu NCT01644617 | ALK-Abelló A/S | Phase 2 |
| Completed | Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008) NCT01678807 | ALK-Abelló A/S | Phase 1 |
| Completed | Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinit NCT01630135 | GlaxoSmithKline | Phase 3 |
| Completed | Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers NCT01216384 | Boehringer Ingelheim | Phase 1 |
| Completed | Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric NCT01135134 | Organon and Co | Phase 3 |
| Unknown | Optimal Concentration of Dermatophagoides Pteronyssinus (Dp) Allergen Extract for Skin Prick Test (SPT) of Tha NCT01172613 | Siriraj Hospital | — |
| Completed | Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis) NCT01134705 | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 3 |
| Completed | A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial All NCT01165424 | Organon and Co | Phase 3 |
| Completed | Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais NCT01115595 | Pongsakorn Tantilipikorn | Phase 4 |
| Completed | Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Al NCT00988247 | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 3 |
| Completed | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoat NCT01231464 | GlaxoSmithKline | Phase 3 |
| Completed | A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110 NCT01270958 | GlaxoSmithKline | Phase 4 |
| Completed | A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on NCT01199757 | GlaxoSmithKline | — |
| Completed | Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI) NCT00829985 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Completed | A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year NCT00682643 | GlaxoSmithKline | Phase 4 |
| Completed | A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis NCT00730756 | GlaxoSmithKline | Phase 2 |
| Completed | Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLET NCT00762983 | Merck Sharp & Dohme LLC | — |
| Completed | Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P056 NCT00761527 | Organon and Co | — |
| Completed | Flixonase Safety in Patients With Allergic Rhinitis (AR) NCT01077609 | GlaxoSmithKline | — |
| Completed | A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year- NCT00609674 | GlaxoSmithKline | Phase 4 |
| Completed | Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study. NCT00570492 | GlaxoSmithKline | Phase 4 |
| Completed | A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose NCT00848965 | GlaxoSmithKline | Phase 4 |
| Completed | Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS NCT00539006 | GlaxoSmithKline | Phase 4 |
| Completed | Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS NCT00519636 | GlaxoSmithKline | Phase 4 |
| Completed | Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis NCT00490204 | GlaxoSmithKline | Phase 3 |
| Completed | Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhin NCT00449072 | Sanofi | Phase 4 |
| Completed | Fluticasone Nasal Spray Patient Preference Study NCT00398476 | GlaxoSmithKline | Phase 3 |
| Completed | Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelasti NCT00806754 | AstraZeneca | Phase 4 |
| Completed | Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental NCT00404586 | GlaxoSmithKline | Phase 1 |
| Completed | Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683) NCT00406783 | Organon and Co | Phase 3 |
| Completed | Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) NCT00346775 | GlaxoSmithKline | Phase 3 |
| Completed | Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR) NCT00289198 | GlaxoSmithKline | Phase 3 |
| Completed | Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunc NCT00232518 | University of Nottingham | N/A |
| Completed | Long Term Safety Of GW685698X Via Nasal Biopsy NCT00224523 | GlaxoSmithKline | Phase 3 |
| Completed | Perennial Allergic Rhinitis In Pediatric Subjects NCT00257595 | GlaxoSmithKline | Phase 3 |
| Terminated | The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis NCT00119015 | University of Chicago | Phase 4 |
| Completed | Study Of Perennial Allergic Rhinitis In Pediatrics NCT00253058 | GlaxoSmithKline | Phase 3 |
| Completed | Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermati NCT02238236 | Boehringer Ingelheim | — |
| Completed | LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis) NCT00160589 | UCB Pharma | Phase 4 |
| Completed | Seasonal Allergic Rhinitis In Pediatric Subjects NCT00107757 | GlaxoSmithKline | Phase 3 |
| Completed | ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life) NCT00160680 | UCB S.A. - Pharma Sector | Phase 4 |
| Completed | A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics NCT00116883 | GlaxoSmithKline | Phase 3 |
| Completed | Perennial Allergic Rhinitis Study In Pediatric Subjects NCT00108914 | GlaxoSmithKline | Phase 3 |
| Completed | Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419) NCT00779740 | Organon and Co | Phase 3 |
| Completed | A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolesce NCT00103454 | GlaxoSmithKline | Phase 3 |
| Completed | A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults NCT00116818 | GlaxoSmithKline | Phase 3 |
| Completed | Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administere NCT00659048 | AstraZeneca | Phase 3 |
| Unknown | EWO1 in Persistent Allergic Rhinitis Patients NCT00153595 | China Medical University Hospital | Phase 2 / Phase 3 |
| Completed | To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perenn NCT00658918 | AstraZeneca | Phase 3 |
| Completed | A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED) NCT00779545 | Organon and Co | Phase 2 |
| Completed | Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet NCT02238223 | Boehringer Ingelheim | — |
| Completed | Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic NCT00159523 | Norwegian University of Science and Technology | N/A |
| Completed | To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allerg NCT00659750 | AstraZeneca | Phase 3 |
| Completed | An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis NCT00132925 | Sanofi | Phase 3 |
| Completed | The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265) NCT00092118 | Organon and Co | Phase 3 |
| Completed | Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults NCT00839189 | University of North Carolina, Chapel Hill | Phase 1 |
| Completed | Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhini NCT00639587 | UCB Pharma | Phase 3 |
| Completed | Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) NCT00092105 | Organon and Co | Phase 3 |
| Completed | Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis NCT00741897 | Sanofi | Phase 4 |
| Completed | WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis NCT02182544 | Boehringer Ingelheim | Phase 3 |
| Completed | Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhi NCT02182518 | Boehringer Ingelheim | Phase 3 |